,39 Mice with experimental CHIP show increased pro-inflammatory drive of the NLRP3/IL-1β/IL-6 axis and atherosclerosis,29,40 and humans carrying a genetic deficiency in IL6 appear to have reduced cardiovascular risk related to CHIP.41 This evidence concerns the gene IL1B and atherosclerosis.